You may also like
Clinical Characteristics Between Survivors and Nonsurvivors of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Support: A Systematic Review and Meta-Analysis
We found advanced age, multiple comorbidities, lower pre-ECMO pH, greater RRT, and vasopressor requirements, and bleeding are predictors of death in COVID-19 patients requiring ECMO support. The duration of MV before ECMO support initiation and total ECMO support duration was similar among survivors and nonsurvivors. Our study results have important clinical implications when considering ECMO support in critically ill COVID-19 patients.
1 min read
Cytomedix, Inc. Expands Patent Litigation Representation by Engaging Leading Litigation Firm
Cytomedix, Inc. (OTC BB:CYME.OB - News) today announced an expansion of the company's patent litigation legal representation with the engagement of Fish & Richardson on a contingent fee basis.
2 min read
